Universe Pharmaceuticals (UPC) Competitors $3.96 -0.06 (-1.49%) Closing price 03:58 PM EasternExtended Trading$3.90 -0.06 (-1.64%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock UPC vs. VRPX, VIRX, NCNA, VINC, CAPS, BON, MYMD, SMFL, SCPS, and VAXXShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include Virpax Pharmaceuticals (VRPX), Viracta Therapeutics (VIRX), NuCana (NCNA), Vincerx Pharma (VINC), Capstone Therapeutics (CAPS), Bon Natural Life (BON), MyMD Pharmaceuticals (MYMD), Smart for Life (SMFL), Scopus BioPharma (SCPS), and Vaxxinity (VAXX). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. Its Competitors Virpax Pharmaceuticals Viracta Therapeutics NuCana Vincerx Pharma Capstone Therapeutics Bon Natural Life MyMD Pharmaceuticals Smart for Life Scopus BioPharma Vaxxinity Universe Pharmaceuticals (NYSE:UPC) and Virpax Pharmaceuticals (NASDAQ:VRPX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation. Is UPC or VRPX more profitable? Universe Pharmaceuticals' return on equity of 0.00% beat Virpax Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Universe PharmaceuticalsN/A N/A N/A Virpax Pharmaceuticals N/A -1,554.34%-338.29% Which has more volatility & risk, UPC or VRPX? Universe Pharmaceuticals has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, Virpax Pharmaceuticals has a beta of 1.58, suggesting that its share price is 58% more volatile than the S&P 500. Does the media prefer UPC or VRPX? In the previous week, Universe Pharmaceuticals' average media sentiment score of 0.00 equaled Virpax Pharmaceuticals'average media sentiment score. Company Overall Sentiment Universe Pharmaceuticals Neutral Virpax Pharmaceuticals Neutral Do insiders & institutionals believe in UPC or VRPX? 0.2% of Universe Pharmaceuticals shares are held by institutional investors. Comparatively, 32.2% of Virpax Pharmaceuticals shares are held by institutional investors. 57.4% of Universe Pharmaceuticals shares are held by insiders. Comparatively, 3.7% of Virpax Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better earnings & valuation, UPC or VRPX? Universe Pharmaceuticals has higher revenue and earnings than Virpax Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniverse Pharmaceuticals$19.29M0.01-$6.16MN/AN/AVirpax PharmaceuticalsN/AN/A-$15.19MN/AN/A Do analysts recommend UPC or VRPX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Universe Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Virpax Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryUniverse Pharmaceuticals beats Virpax Pharmaceuticals on 5 of the 8 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$170K$782.13M$5.59B$20.78BDividend YieldN/A4.84%4.71%3.60%P/E RatioN/A1.3627.9627.72Price / Sales0.0124.78389.5467.40Price / CashN/A19.5636.3223.29Price / Book0.026.688.374.52Net Income-$6.16M-$4.52M$3.25B$993.24M7 Day Performance3.39%-1.96%-2.50%-2.56%1 Month Performance5.60%5.23%7.98%2.01%1 Year Performance-99.82%12.18%34.65%8.22% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse PharmaceuticalsN/A$3.96-1.5%N/A-99.8%$170K$19.29M0.00220Gap DownVRPXVirpax PharmaceuticalsN/A$0.33-17.5%N/A-99.8%$410KN/A0.007Gap DownVIRXViracta Therapeutics1.9893 of 5 stars$0.01flat$1.75+17,793.7%N/A$389KN/A-0.0120News CoverageNCNANuCana3.2891 of 5 stars$0.05+6.9%$25.00+48,919.6%-98.6%$290KN/A-0.0130Gap UpHigh Trading VolumeVINCVincerx Pharma2.6367 of 5 stars$0.05+9.5%$40.00+80,708.1%-99.7%$259KN/A0.0060Gap UpCAPSCapstone TherapeuticsN/A$1.62flatN/AN/A$255K$43.42M0.0038News CoverageBONBon Natural Life0.5362 of 5 stars$1.42+0.7%N/AN/A$240K$23.84M0.00100Gap UpMYMDMyMD PharmaceuticalsN/A$0.09-7.6%N/A-93.9%$207KN/A0.006Gap DownHigh Trading VolumeSMFLSmart for LifeN/A$0.02+1.9%N/A-99.9%$150K$11.11M0.00110SCPSScopus BioPharmaN/A$0.00flatN/AN/A$13KN/A0.009VAXXVaxxinityN/A$0.00flatN/A-60.0%$13KN/A0.0090Gap Up Related Companies and Tools Related Companies VRPX Alternatives VIRX Alternatives NCNA Alternatives VINC Alternatives CAPS Alternatives BON Alternatives MYMD Alternatives SMFL Alternatives SCPS Alternatives VAXX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:UPC) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredStrange Investment Secret Predicts Market's Next Move?A strange market signal discovered before the Great Depression has predicted nearly every major financial even...Weiss Ratings | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
